JPH0587488B2 - - Google Patents

Info

Publication number
JPH0587488B2
JPH0587488B2 JP59268592A JP26859284A JPH0587488B2 JP H0587488 B2 JPH0587488 B2 JP H0587488B2 JP 59268592 A JP59268592 A JP 59268592A JP 26859284 A JP26859284 A JP 26859284A JP H0587488 B2 JPH0587488 B2 JP H0587488B2
Authority
JP
Japan
Prior art keywords
release
weight
cellulose
preparation
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP59268592A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61148115A (ja
Inventor
Takeshi Nara
Tokuo Hatori
Yozo Nishinomya
Hisashi Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toa Eiyo Ltd
Original Assignee
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Eiyo Ltd filed Critical Toa Eiyo Ltd
Priority to JP26859284A priority Critical patent/JPS61148115A/ja
Publication of JPS61148115A publication Critical patent/JPS61148115A/ja
Publication of JPH0587488B2 publication Critical patent/JPH0587488B2/ja
Granted legal-status Critical Current

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2210/00—Fluid
    • F04C2210/26—Refrigerants with particular properties, e.g. HFC-134a

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP26859284A 1984-12-21 1984-12-21 難溶性薬物の徐放性製剤及びその製造法 Granted JPS61148115A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26859284A JPS61148115A (ja) 1984-12-21 1984-12-21 難溶性薬物の徐放性製剤及びその製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26859284A JPS61148115A (ja) 1984-12-21 1984-12-21 難溶性薬物の徐放性製剤及びその製造法

Publications (2)

Publication Number Publication Date
JPS61148115A JPS61148115A (ja) 1986-07-05
JPH0587488B2 true JPH0587488B2 (enrdf_load_stackoverflow) 1993-12-16

Family

ID=17460672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26859284A Granted JPS61148115A (ja) 1984-12-21 1984-12-21 難溶性薬物の徐放性製剤及びその製造法

Country Status (1)

Country Link
JP (1) JPS61148115A (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
IT1213508B (it) * 1986-10-22 1989-12-20 Foscama Biomed Chim Farma Preparato farmaceutico a base di buflomedil cloridrato, sotto formadi compresse a rilascio controllato e relativo procedimento di preparazione.
JP2708803B2 (ja) * 1987-09-02 1998-02-04 中外製薬株式会社 持続放出製剤
TW209174B (enrdf_load_stackoverflow) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
GB9713549D0 (en) * 1996-10-18 1997-09-03 Euro Celtique Sa Pharmaceutical combination formulation
JP4696210B2 (ja) * 2000-06-07 2011-06-08 トーアエイヨー株式会社 イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
JP2005029523A (ja) * 2003-07-09 2005-02-03 Eisai Co Ltd 新規錠剤
WO2005123045A2 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release matrix pharmaceutical dosage formulation
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
KR100990590B1 (ko) * 2005-09-01 2010-10-29 에자이 알앤드디 매니지먼트 가부시키가이샤 붕해성이 개선된 의약 조성물의 제조 방법
WO2012166899A2 (en) 2011-06-03 2012-12-06 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
EP2997377B1 (en) 2013-05-14 2018-07-18 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
SMT202200367T1 (it) 2014-08-28 2022-11-18 Eisai R&D Man Co Ltd Derivato di chinolina a elevata purezza e metodo per la produzione dello stesso
CA2976325C (en) 2015-02-25 2023-07-04 Eisai R&D Management Co., Ltd. Method for suppressing bitterness of quinoline derivative
WO2016140717A1 (en) 2015-03-04 2016-09-09 Merck Sharp & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
RU2729936C2 (ru) 2015-06-16 2020-08-13 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Противораковое средство
KR102587702B1 (ko) 2015-08-20 2023-10-12 에자이 알앤드디 매니지먼트 가부시키가이샤 종양 치료제
JP6581320B2 (ja) 2017-02-08 2019-09-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍治療用医薬組成物
AU2018269996A1 (en) 2017-05-16 2019-11-21 Eisai R&D Management Co., Ltd. Treatment of hepatocellular carcinoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58109412A (ja) * 1981-12-23 1983-06-29 Toa Eiyou Kagaku Kogyo Kk ニフエジピン固形製剤

Also Published As

Publication number Publication date
JPS61148115A (ja) 1986-07-05

Similar Documents

Publication Publication Date Title
RU2245148C2 (ru) Фармацевтическая композиция на основе месалазина для перорального введения с регулируемым высвобождением активного ингредиента
FI91482B (fi) Menetelmä hitaasti vapauttavan kiinteän annostusmuodon valmistamiseksi
JPH0587488B2 (enrdf_load_stackoverflow)
EP0196700B1 (en) Devices for the controlled release of active substances, as well as process for the preparation thereof
DE69923200T2 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
US5051263A (en) Controlled-release formulations
EP0120118B1 (en) Constant release rate solid oral dosage formulations of cardiovascular drugs
RU2235540C2 (ru) Способ получения пероральной препаративной формы пролонгированного действия с регулируемым высвобождением активного вещества в зависимости от вида и количества наполнения желудка и пищеварительного тракта
US4837032A (en) Theophylline sustained release tablet
JPH0122245B2 (enrdf_load_stackoverflow)
EP1293208A1 (en) Pharmaceutical formulation
US5234691A (en) Sustained-release prepararation of basic medical agent hydrochloride
WO2002043706A9 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
JPH09323926A (ja) バルプロ酸ナトリウムの徐放性錠剤
JPS62120315A (ja) 経口投与型徐放性錠剤の製造方法
EP0297866A2 (en) Therapeutic agents
JP7650033B2 (ja) ニトロキソリンを含む医薬組成物、ニトロキソリン経口固形錠剤、その調製方法、及びその使用
CN115721600A (zh) 一种胃滞留型普瑞巴林缓释组合物及其制备方法
CN114796134A (zh) 一种易于快速完全崩解的聚卡波非钙片剂
CN112168796A (zh) 双相缓释系统控制释放的药物缓释制剂及其制备方法
JPH04264021A (ja) 持続性錠剤
JPS6133007B2 (enrdf_load_stackoverflow)
KR100216624B1 (ko) 경구투여용 서방성 제제
KR100540037B1 (ko) 펠로디핀의 지속성 정제 및 그 제조방법
WO2024213341A1 (en) Sustained release dosage forms comprising complexes of low solutibility compounds, and methods for their preparation

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees